Monitorforhire.com Signs Agreement with Global CINRG
Monitorforhire.com (MFH) has signed an agreement with Global CINRG to provide monitors for their clinical trials.
PHILADELPHIA, May 17, 2005-Monitorforhire.com (MFH) has signed an agreement with Global CINRG to provide monitors for their clinical trials. The agreement will provide the Sacramento, Ca.-based clinical research management organization (RMO) with access to more than 2,000 qualified, pre-screened clinical monitors worldwide with expertise in a variety of therapeutic specialties.
"We are delighted to be working with Global CINRG," said Scott Freedman, president, Monitorforhire.com. "As the only web-based provider of clinical monitoring services, we are uniquely positioned to help Global CINRG meet its goals."
Global CINRG is a worldwide clinical research management organization. They combine extensive international research competence with a prescreened, pre-qualified global research enrollable patient database (REDbase).
Monitorforhire.com has registered monitors located in all 50 states of the US. and 28 countries worldwide. Its growing client base currently consists of more than 300 clinical sponsors including major pharmaceutical, biotechnology companies, academic institutions and CROs.
About Monitorforhire.com
Monitor for hire is the leading web-enabled resource management company providing qualified, regional independent clinical monitors to the pharmaceutical, biotechnology, medical device and contract research industries. The service allows registered sponsors to query the online system for pre-qualified, available monitors by therapeutic experience, indication experience and geographic location. Monitorforhire.com has offices in Philadelphia, Pa. and San Diego, Ca. For more information, please visit www.monitorforhire.com or call (610) 862.0909 on the U.S. East Coast or (858) 453.8030 on the West Coast.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
